Valneva and Pfizer Complete Recruitment for Phase 2 Trial of Lyme Disease Vaccine Candidate

NEXT STORY
Scientific Article Covering Immune Modulating Interstitial Laser Thermotherapy by CLS’ Co-founder Professor Karl-Göran Tranberg Published in the Journal “Frontiers in Oncology”
PREV STORY
Ninety Day Survival Outcomes in COVID-19 ARDS Trial of Remestemcel-L Presented at ISCT Meeting on Advances in Cell & Gene Therapies for Lung Diseases
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Summit Announces Publication of Phase 2 Clinical Analyses of Gut Microbiome Health

author_avatar
NASDAQ Market News

Basilea gibt Clinical Trial Collaboration and Supply Agreement mit Eli Lilly and Company für Ramucirumab für die laufende FIDES-03-Studie mit Derazantinib bei Magenkrebs bekannt

author_avatar
NASDAQ Market News

OSE Immunotherapeutics Receives Belgian Authorization for a Phase 1 Clinical Trial to Evaluate Anti-IL-7 Receptor Antagonist OSE-127

NANTES, France, Nov. 26, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: ...

author_avatar
NASDAQ Market News